Another study conducted on PBMCs isolated from blood samples of non-smokers, non-obstructive smokers, and patients with COPD of all stages, including exacerbation, showed that levels of the DNA damage, PARP-1 activity and PARP-1 mRNA expression were found to be increased with progression of the disease. Here, PARP1 is linked to chronic obstructive pulmonary disease.